Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATx201 in Healthy Volunteers and Patients with Infected Atopic Dermatitis
NCT03009734Phase 2Completed
- Sponsor
- UNION therapeutics
- Start
- Dec 2016
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niclosamide in atopic dermatitis (AD), sponsored by UNION therapeutics. Started Dec 2016; status: completed.
02
Drugs
niclosamide
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03009734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03009734.